Exhibition Preview! VESBER Participates in Euretina Congress to Showcase Chinese Ophthalmic Innovative Technologies
Release time: Sep 13,2024
Exhibition Preview! VESBER Participates in Euretina Congress to Showcase Chinese Ophthalmic Innovative Technologies


The 24th Congress of the European Society of Retina Specialists (Euretina 2024) will be held at the Barcelona International Convention Center (CCIB), Spain, from September 19 to 22, 2024. Recognized as a pivotal gathering for retina specialists, this congress serves as a key hub to uncover the latest frontiers in retinal care. Throughout the event, participants can immerse themselves in rich knowledge-sharing and explore breakthrough developments. As the event commences, attendees will have the opportunity to witness firsthand the advancements in retinal science, emerging therapies, and innovative strategies transforming patient care.
Hundreds of exhibitors from around the world will participate in the exhibition. VESBER, a Chinese ophthalmic innovation leader, will set up a booth at the congress, allowing more international experts to gain insights into China’s cutting-edge ophthalmic technologies.
VESBER Booth: A2
VESBER will showcase its globally innovative products—the Foldable Capsular Vitreous Balloon (FCVB) and Foldable Buckling Balloon (FCB)—at booth A2. We warmly welcome all experts to visit and guide us!

Key Product Highlights:
Foldable Capsular Vitreous Balloon (FCVB):
An internationally innovative product mimicking the natural vitreous body. Since its debut on the global ophthalmic stage, FCVB has been clinically applied in 11 countries: the UK, Belgium, Greece, Turkey, the Netherlands, Poland, Latvia, Pakistan, Georgia, Russia, and Australia. It has received acclaim and recognition from renowned international ophthalmologists and sparked extensive attention and discussions on artificial vitreous substitutes at major ophthalmic conferences.


Foldable Buckling Balloon (FCB):
A minimally invasive external approach for rhegmatogenous retinal detachment featuring 5 "No"s:
- No retrobulbar anesthesia
- No muscle traction
- No scleral fluid drainage
- No intraoperative localization
- No retinal cryopexy
This revolutionary technology overturns traditional external retinal detachment treatment, significantly reducing surgery time and becoming the preferred choice for retinal detachment the rapy.

About VESBER:
Committed to driving innovation in ophthalmology, VESBER is dedicated to providing innovative treatment products and technologies for ophthalmic patients. We eagerly anticipate sharing our latest innovations with global ophthalmic professionals at this prestigious retinal congress, demonstrating China’s outstanding achievements and potential in the ophthalmic field. We warmly welcome all experts to visit our booth for technical guidance!
As a pioneer in FCVB surgery since 2021, Sichuan Provincial People’s Hospital has performed this procedure for nearly 20 patients suffering from ocular trauma and silicone oil dependency to safeguard their ocular health with professional expertise. It represents the inheritance and upgrading of the hospital’s diagnostic and treatment technologies, as well as its commitment to delivering high-quality, precise medical services for patients with complex eye diseases.
04/16
Compared to conventional surgery, FCB implantation offers significant advantages. The procedure requires only a 4mm conjunctival incision, causes minimal tissue damage, and results in less postoperative pain and faster recovery.
04/12